OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT04691687
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- New York Presbyterian Brooklyn Methodist Hospital
- Registry
-
NCT04691687
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT04691687. Randomized; quadruple masking; primary purpose treatment. Start 2012-05-01 (actual); primary completion 2017-12-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure
- Acronym
- OUTLAST
- Condition
- Heart Failure
- Intervention (Drug)
- Furosemide
- Intervention (Drug)
- IV Solution
- Lead sponsor
- New York Presbyterian Brooklyn Methodist Hospital
Record details
- Record id
cardio:ct-nct04691687- Content hash
14b73dc74916b15e0714aff061100ee37b626e1a5ac031a51bbb0a554f1995d9